Clinical Trial Approved - First two days - Advanced EGFR Exon 20 - LMD. Kyle & Jenny Appleford. DIAGNOSIS: March 19th, 2021 Stage IIIA Non Small Cell Lung Cancer (Non-Smoking) February 2022 Stage IV Non Small Cell Lung Cancer (spreading to Brain, and other parts of lung and lymph nodes) Gene Mutation EGFR with Exon 20 Insertion TREATMENTS: Received or currently Receiving 2021: 8 Rounds of Chemotherapy (Carboplatin and Paclitaxel) with 30 concurrent radiation treatments to chest and lung Failed I